Commodore Capital LP Seres Therapeutics, Inc. Transaction History

Commodore Capital LP

  • $1.18 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$5.46 - $22.6 $794,173 - $3.29 Million
-145,453 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$18.46 - $24.36 $76,609 - $101,094
4,150 Added 2.94%
145,453 $3.47 Million
Q1 2021

May 17, 2021
BUY
$17.66 - $28.92 $2.5 Million - $4.09 Million
141,303 New
141,303 $2.91 Million

Others Institutions Holding MCRB

# of Institutions
82
Shares Held
40.5M
Call Options Held
304K
Put Options Held
471K
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $100M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Commodore Capital LP Portfolio

Follow Commodore Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commodore Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Commodore Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email